Global Biobanking Sample Market Size By Type (Blood s, Human Tissues), By Application (Regenerative Medicine, Life Science Research), By Region, And Segment Forecasts, 2023 to 2032

The Global Biobanking Sample Market was valued at USD 52.6 billion in 2023 and is projected to reach USD 91.2 billion by 2031, expanding at a CAGR of 7.1% during the forecast period (2023–2031). The market is witnessing robust growth due to the increasing demand for personalized medicine, advancements in genomic research, and the rising prevalence of chronic diseases. Biobanks are playing a pivotal role in biomedical research by providing high-quality biological samples, aiding in drug development, disease research, and clinical trials. As precision medicine gains traction, the need for standardized, well-maintained sample repositories is expanding across both developed and developing economies.

Drivers:

1. Growing Emphasis on Precision Medicine:

Biobanking is foundational for precision medicine, enabling the identification of biomarkers, genetic traits, and patient-specific therapeutic strategies. This growing emphasis is driving demand for well-maintained sample repositories.

2. Advancements in Genomic and Proteomic Research:

The continuous evolution of genomics and proteomics has increased the requirement for high-quality biological samples. Biobanks facilitate long-term sample preservation, enabling large-scale, longitudinal research studies.

3. Rising Incidence of Chronic Diseases:

With chronic diseases such as cancer, diabetes, and cardiovascular disorders on the rise globally, the need for biobanks to support diagnostic and therapeutic research is growing substantially.

Restraints:

1. Ethical and Regulatory Challenges:

Concerns related to donor consent, privacy, and data protection can impede biobank operations, especially across borders where regulations vary.

2. High Operational and Storage Costs:

Maintaining sample integrity requires sophisticated storage solutions (e.g., cryogenic systems), which come with significant financial and logistical burdens.

Opportunity:

1. Integration of AI and Data Analytics in Biobanking:

The integration of AI and big data tools to analyze large biobank datasets is opening new frontiers for disease prediction, early diagnostics, and personalized treatment development.

2. Expansion in Emerging Markets:

Countries in Asia-Pacific, Latin America, and the Middle East are investing heavily in healthcare infrastructure, creating fertile ground for biobanking initiatives.

3. Increased Collaboration between Academia and Industry:

Collaborations between research institutions, biotech firms, and pharmaceutical companies are accelerating innovation and market penetration.

Market by System Type Insights:

By system type, the Automated Biobanking Systems segment led the market in 2023. These systems offer precise temperature control, real-time inventory management, and minimal human error, making them the preferred choice for large-scale sample storage and handling. Manual biobanking systems still hold relevance in low-resource settings but are expected to decline in market share over time.

Market by End-use Insights:

In 2023, the Pharmaceutical & Biotechnology Companies segment emerged as the dominant end-user, contributing to over 45% of global revenue. These organizations utilize biobanks for drug discovery, clinical trials, and biomarker validation. The Academic & Research Institutions segment is also witnessing rapid growth, supported by increased funding and government-led health research initiatives.

Market by Regional Insights:

North America held the largest share of the global biobanking sample market in 2023, driven by advanced healthcare infrastructure, strong funding mechanisms, and early adoption of precision medicine practices. Asia-Pacific is anticipated to register the fastest growth rate during the forecast period, buoyed by population growth, increasing R&D investments, and supportive government policies in countries like China, India, and South Korea.

Competitive Scenario:

Key players operating in the Global Biobanking Sample Market include:

Thermo Fisher Scientific Inc.

Brooks Life Sciences (Azenta Life Sciences)

Tecan Group Ltd.

Qiagen N.V.

BioLife Solutions Inc.

Hamilton Company

Greiner Bio-One International GmbH

BD Biosciences

Merck KGaA

Lonza Group AG

These companies are focusing on strategic acquisitions, automation technology, and expanding their global biobank infrastructure to enhance market presence.

Scope of Work – Global Biobanking Sample Market

Report Metric Details

Market Size (2023) USD 52.6 Billion

Projected Market Size (2031) USD 91.2 Billion

CAGR (2023–2031) 7.1%

Market Segments System Type (Automated, Manual), End-use (Pharma & Biotech Companies, Academic & Research Institutions, Hospitals), Region

Growth Drivers Demand for precision medicine, growth in genomic research, rise in chronic diseases

Opportunities AI integration, emerging market expansion, academia-industry partnerships

Key Market Developments:

June 2023: Thermo Fisher Scientific introduced an AI-powered sample tracking system integrated into its automated biobanking platform to streamline sample inventory management.

March 2024: BioLife Solutions acquired a cryogenic storage technology provider to strengthen its position in automated biopreservation systems.

January 2025: Qiagen launched a collaboration with a leading Asian medical research institute to develop a regional biobank supporting oncology research.

FAQs:

1) What is the current market size of the Global Biobanking Sample Market?

The market size was valued at USD 52.6 billion in 2023.

2) What is the major growth driver of the Global Biobanking Sample Market?

The key growth driver is the increasing demand for personalized medicine and advancements in genomic research.

3) Which is the largest region during the forecast period in the Global Biobanking Sample Market?

North America holds the largest market share due to advanced healthcare infrastructure and R&D investments.

4) Which segment accounted for the largest market share in the Global Biobanking Sample Market?

The Pharmaceutical & Biotechnology Companies segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Biobanking Sample Market?

Leading players include Thermo Fisher Scientific, Qiagen, Hamilton Company, BioLife Solutions, and Tecan Group.

Let me know if you want a PDF version of this description or want to generate another one!